全氟和多氟烷基物质与中年女性新发糖尿病:全国女性健康研究(SWAN)
该前瞻性队列纳入1237名基线无糖尿病的45-56岁女性,随访至2017年。调整混杂后,n-PFOA、PFHxS、MeFOSAA及四种常见PFAS之和的最高三分位组较低三分位组糖尿病风险升高,七种PFAS混合物最高较低三分位组HR为2.62(95%CI 1.12, 6.20)。研究提示PFAS可能增加中年女性糖尿病风险。
要点
- n-PFOA最高较低三分位组HR 1.67(95%CI 1.21, 2.31),趋势P=0.001。
- 七种PFAS混合物最高较低三分位组HR 2.62(95%CI 1.12, 6.20)。
- 研究提示PFAS可能增加中年女性糖尿病风险。
核心结论
- 本研究提示PFAS可能增加中年女性糖尿病风险。
- 作者认为减少暴露于这些「永久且无处不在的化学物质」可能是降低人群糖尿病风险的重要预防途径。
研究设计与样本
- 研究为前瞻性队列研究,纳入全国女性健康研究多污染物研究(SWAN-MPS)中基线(1999-2000年)无糖尿病的45-56岁女性1237名,随访至2017年。
- 采用在线固相萃取-HPLC-同位素稀释-串联质谱定量11种PFAS血清浓度,将检出率>96%的7种PFAS纳入分析。
- 使用Cox比例风险模型计算HR和95%CI,并采用基于分位数的g计算评估PFAS混合物的联合效应。
主要发现
- 调整种族/民族、中心、教育、吸烟状态、饮酒、总能量摄入、体力活动、绝经状态和BMI后,n-PFOA最低较最高三分位组HR为1.67(95%CI 1.21, 2.31),趋势P=0.001。
- PFHxS最低较最高三分位组HR为1.58(95%CI 1.13, 2.21),趋势P=0.003。
- Sm-PFOS最低较最高三分位组HR为1.36(95%CI 0.97, 1.90),趋势P=0.05。
- MeFOSAA最低较最高三分位组HR为1.85(95%CI 1.28, 2.67),趋势P=0.0004。
- 四种常见PFAS(n-PFOA、PFNA、PFHxS和总PFOS)之和最低较最高三分位组HR为1.64(95%CI 1.17, 2.31),趋势P=0.002;七种PFAS混合物最高较最低三分位组HR为2.62(95%CI 1.12, 6.20)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Diabetogenic effects of per- and polyfluoroalkyl substances (PFAS) have been suggested. However, evidence based on prospective cohort studies is limited. We examined the association between serum PFAS concentrations and incident diabetes in the Study of Women's Health Across the Nation Multi-Pollutant Study (SWAN-MPS). METHODS: We included 1237 diabetes-free women aged 45-56 years at baseline (1999-2000) who were followed up to 2017. At each follow-up visit, women with incident diabetes were identified by the presence of one or more of the following conditions: (1) use of a glucose-lowering medication at any visit; (2) fasting glucose ≥7 mmol/l on two consecutive visits while not on steroids; and (3) any two visits with self-reported diabetes and at least one visit with fasting blood glucose ≥7 mmol/l. Serum concentrations of 11 PFAS were quantified by online solid-phase extraction-HPLC-isotope dilution-tandem MS. Seven PFAS with high detection rates (>96%) (n-perfluorooctanoic acid [n-PFOA], perfluorononanoic acid [PFNA], perfluorohexane sulfonic acid [PFHxS], n-perfluorooctane sulfonic acid [n-PFOS], sum of perfluoromethylheptane sulfonic acid isomers [Sm-PFOS], 2-[N-methyl-perfluorooctane sulfonamido] acetic acid [MeFOSAA] and 2-[N-ethyl-perfluorooctane sulfonamido] acetic acid) were included in data analysis. Cox proportional hazards models were used to compute HRs and 95% CIs. Quantile-based g-computation was used to evaluate the joint effects of PFAS mixtures. RESULTS: After adjustment for race/ethnicity, site, education, smoking status, alcohol consumption, total energy intake, physical activity, menopausal status and BMI, the HR (95% CI) comparing the lowest with the highest tertile was 1.67 (1.21, 2.31) for n-PFOA (ptrend = 0.001), 1.58 (1.13, 2.21) for PFHxS (ptrend = 0.003), 1.36 (0.97, 1.90) for Sm-PFOS (ptrend = 0.05), 1.85 (1.28, 2.67) for MeFOSAA (ptrend = 0.0004) and 1.64 (1.17, 2.31) for the sum of four common PFAS (n-PFOA, PFNA, PFHxS and total PFOS) (ptrend = 0.002). Exposure to seven PFAS as mixtures was associated with an HR of 2.62 (95% CI 1.12, 6.20), comparing the top with the bottom tertiles for all seven PFAS. CONCLUSIONS/INTERPRETATION: This study suggests that PFAS may increase diabetes risk in midlife women. Reduced exposure to these 'forever and everywhere chemicals' may be an important preventative approach to lowering population-wide diabetes risk.
引用
- Park SK, Wang X, Ding N, et al. Per- and polyfluoroalkyl substances and incident diabetes in midlife women: the Study of Women's Health Across the Nation (SWAN). Diabetologia. 2022. PMID: 35399113. doi:10.1007/s00125-022-05695-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。